Abstract
In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support. (Funded by the Medical Research Council and National Institute for Health Research and others; RECOVERY ClinicalTrials.gov number, NCT04381936; ISRCTN number, 50189673.).
MeSH Terms
AdministrationOralAgedAged80 and overAnti-Infective AgentsCOVID-19DexamethasoneDrug TherapyCombinationFemaleGlucocorticoidsHospitalizationHumansInjectionsIntravenousKaplan-Meier EstimateLength of StayMaleOdds RatioOxygen Inhalation TherapyRespirationArtificialUnited KingdomCOVID-19 Drug Treatment
Related Publications
Dexamethasone in Hospitalized Patients with Covid-19.
BACKGROUND: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progres...
Remdesivir for the Treatment of Covid-19 — Final Report
Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory trac...
Viral Loads in Clinical Specimens and SARS Manifestations
A retrospective viral load study was performed on clinical specimens from 154 patients with laboratory-confirmed severe acute respiratory syndrome (SARS); the specimens were pro...
Clinical Characteristics of Coronavirus Disease 2019 in China
BACKGROUND: Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical charac...
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...
Publication Info
- Year
- 2020
- Type
- article
- Volume
- 384
- Issue
- 8
- Pages
- 693-704
- Citations
- 9762
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
9762
OpenAlex
35
Influential
7723
CrossRef
Cite This
(2020).
Dexamethasone in Hospitalized Patients with Covid-19.
New England Journal of Medicine
, 384
(8)
, 693-704.
https://doi.org/10.1056/nejmoa2021436
Identifiers
- DOI
- 10.1056/nejmoa2021436
- PMID
- 32678530
- PMCID
- PMC7383595